Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maha Hussain

Showing results (21-30 of 213) with videos related to

Pageof 22
Sort By:
Seminars in Oncology|June 29, 2013
Non-castrate metastatic prostate cancer: have the treatment options changed?Phillip L Palmbos, Maha Hussain
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Why Chemotherapy Should be Given Early for Men with Metastatic Prostate CancerLeonel F Hernandez-Aya, Maha Hussain
European Urology Focus|February 27, 2019
Revisiting Intermittent Therapy in Metastatic Prostate Cancer: Can Less Be More in the "New World Order"?Jeffrey Shevach, Matthew R Sydes, Maha Hussain
American Journal of Translational Research|September 10, 2011
Urothelial carcinomas: a focus on human epidermal receptors signalingPetros D Grivas, Mark Day, Maha Hussain
Oncology (Williston Park, N.Y.)|November 16, 2005
Management of patients with muscle-invasive and metastatic bladder cancerN Lynn Henry, Gary MacVicar, Maha Hussain
Seminars in Oncology|March 15, 2002
Novel gemcitabine-containing triplets in the management of urothelial cancerMaha Hussain, Ulka Vaishampayan, David C Smith
Seminars in Oncology|March 27, 2007
New molecular targets and novel agents in the treatment of advanced urothelial cancerKathleen W Beekman, Deborah Bradley, Maha Hussain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Should intermittent androgen deprivation be used in routine clinical practice?Manish S Bhandari, Juanita Crook, Maha Hussain
American Journal of Clinical Oncology|December 4, 2004
Phase II trial of estramustine and etoposide in androgen-sensitive metastatic prostate carcinomaUlka Vaishampayan, Joseph Fontana, Wei Du, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2005
Clinical trials in metastatic prostate cancer--has there been real progress in the past decade?Manish S Bhandari, Daniel P Petrylak, Maha Hussain
Pageof 22

Showing results (21-30 of 213) with videos related to

Sort By:
Pageof 22
Seminars in Oncology|June 29, 2013
Non-castrate metastatic prostate cancer: have the treatment options changed?Phillip L Palmbos, Maha Hussain
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Why Chemotherapy Should be Given Early for Men with Metastatic Prostate CancerLeonel F Hernandez-Aya, Maha Hussain
European Urology Focus|February 27, 2019
Revisiting Intermittent Therapy in Metastatic Prostate Cancer: Can Less Be More in the "New World Order"?Jeffrey Shevach, Matthew R Sydes, Maha Hussain
American Journal of Translational Research|September 10, 2011
Urothelial carcinomas: a focus on human epidermal receptors signalingPetros D Grivas, Mark Day, Maha Hussain
Oncology (Williston Park, N.Y.)|November 16, 2005
Management of patients with muscle-invasive and metastatic bladder cancerN Lynn Henry, Gary MacVicar, Maha Hussain
Seminars in Oncology|March 15, 2002
Novel gemcitabine-containing triplets in the management of urothelial cancerMaha Hussain, Ulka Vaishampayan, David C Smith
Seminars in Oncology|March 27, 2007
New molecular targets and novel agents in the treatment of advanced urothelial cancerKathleen W Beekman, Deborah Bradley, Maha Hussain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Should intermittent androgen deprivation be used in routine clinical practice?Manish S Bhandari, Juanita Crook, Maha Hussain
American Journal of Clinical Oncology|December 4, 2004
Phase II trial of estramustine and etoposide in androgen-sensitive metastatic prostate carcinomaUlka Vaishampayan, Joseph Fontana, Wei Du, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2005
Clinical trials in metastatic prostate cancer--has there been real progress in the past decade?Manish S Bhandari, Daniel P Petrylak, Maha Hussain
Pageof 22